PL2833891T3 - Kompozycja do leczenia mukowiscydozy i do indukcji wydzielania jonów - Google Patents

Kompozycja do leczenia mukowiscydozy i do indukcji wydzielania jonów

Info

Publication number
PL2833891T3
PL2833891T3 PL13772867T PL13772867T PL2833891T3 PL 2833891 T3 PL2833891 T3 PL 2833891T3 PL 13772867 T PL13772867 T PL 13772867T PL 13772867 T PL13772867 T PL 13772867T PL 2833891 T3 PL2833891 T3 PL 2833891T3
Authority
PL
Poland
Prior art keywords
compostion
induction
treatment
cystic fibrosis
ion secretion
Prior art date
Application number
PL13772867T
Other languages
English (en)
Inventor
Sadasivan Vidyasagar
Paul Okunieff
Sreekala PRABHAKARAN
Lurong Zhang
Original Assignee
University Of Florida Research Foundation, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Of Florida Research Foundation, Inc. filed Critical University Of Florida Research Foundation, Inc.
Publication of PL2833891T3 publication Critical patent/PL2833891T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
PL13772867T 2012-04-05 2013-03-15 Kompozycja do leczenia mukowiscydozy i do indukcji wydzielania jonów PL2833891T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261620758P 2012-04-05 2012-04-05
US201261637675P 2012-04-24 2012-04-24
PCT/US2013/031970 WO2013151744A1 (en) 2012-04-05 2013-03-15 Materials and methods for treatment of cystic fibrosis and for induction of ion secretion
EP13772867.1A EP2833891B1 (en) 2012-04-05 2013-03-15 Compostion for treatment of cystic fibrosis and for induction of ion secretion

Publications (1)

Publication Number Publication Date
PL2833891T3 true PL2833891T3 (pl) 2019-01-31

Family

ID=49300925

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13772867T PL2833891T3 (pl) 2012-04-05 2013-03-15 Kompozycja do leczenia mukowiscydozy i do indukcji wydzielania jonów

Country Status (6)

Country Link
US (2) US10086007B2 (pl)
EP (1) EP2833891B1 (pl)
CA (1) CA2869430A1 (pl)
ES (1) ES2691083T3 (pl)
PL (1) PL2833891T3 (pl)
WO (1) WO2013151744A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG188293A1 (en) 2010-09-24 2013-04-30 Univ Florida Materials and methods for improving gastrointestinal function
MX361647B (es) 2013-03-11 2018-12-13 Univ Florida Materiales y métodos para mejorar la función pulmonar y para la prevención y/o tratamiento de complicaciones pulmonares inducidas por radiación.
US11878073B1 (en) 2022-09-20 2024-01-23 Entrinsic, LLC Generation of hydration-targeted formulations and methods of use therein

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994016758A1 (en) 1991-03-05 1994-08-04 Miris Medical Corporation A medication cassette for an automatic aerosol medication delivery system
ATE189124T1 (de) 1991-07-02 2000-02-15 Inhale Inc Verfahren und vorrichtung zum abgeben von medikamenten in aerosolform
US6582728B1 (en) 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
US5558085A (en) 1993-01-29 1996-09-24 Aradigm Corporation Intrapulmonary delivery of peptide drugs
US5934272A (en) 1993-01-29 1999-08-10 Aradigm Corporation Device and method of creating aerosolized mist of respiratory drug
US6051256A (en) 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
JPH11507831A (ja) * 1995-06-14 1999-07-13 ベイラー・カレッジ・オブ・メディスン ロタウイルスエンテロトキシンｎｓｐ４およびそれを用いる方法
US6673355B1 (en) 1995-06-14 2004-01-06 Baylor College Of Medicine Rotavirus enterotoxin NSP4 and methods of using same
WO1998029140A1 (en) 1996-12-31 1998-07-09 Inhale Therapeutic Systems Processes and compositions for spray drying hydrophobic drugs in organic solvent suspensions of hydrophilic excipients
AU776679B2 (en) 1998-11-13 2004-09-16 Children's Hospital Of Los Angeles Methods of facilitating vascular growth
EP2191718A1 (en) * 1998-12-22 2010-06-02 The University of North Carolina at Chapel Hill Compounds and uses for the treatment of airway diseases and for the delivery of airway drugs
WO2012020357A1 (en) * 2010-08-09 2012-02-16 Advinus Therapeutics Ltd. Acetamide compounds, their process and pharmaceutical application

Also Published As

Publication number Publication date
WO2013151744A9 (en) 2014-03-27
WO2013151744A1 (en) 2013-10-10
CA2869430A1 (en) 2013-10-10
EP2833891A4 (en) 2015-12-02
US20150044145A1 (en) 2015-02-12
ES2691083T3 (es) 2018-11-23
US20190000865A1 (en) 2019-01-03
EP2833891B1 (en) 2018-07-25
EP2833891A1 (en) 2015-02-11
US10086007B2 (en) 2018-10-02

Similar Documents

Publication Publication Date Title
HK1220610A1 (zh) 噠嗪酮化合物和用於治療囊腫狀纖維化的方法
HRP20180939T1 (hr) Kombinirana terapija za liječenje multiple skleroze
EP2968285A4 (en) COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS
HK1207574A1 (en) Treatment of myelosuppression
ZA201408466B (en) Apparatuses and methods for wound therapy
IL260115A (en) Methods for treating fibrosis (Leifat)
HK1224210A1 (zh) 用於治療纖維化的方法和組合物
PT2664326T (pt) Terapia combinada para a fibrose quística
IL234813A0 (en) Methods for increasing the efficacy of cd37-based therapy
EP3016944A4 (en) COMPOUNDS FOR THE TREATMENT OF CYSTIC FIBROSIS
PL2833891T3 (pl) Kompozycja do leczenia mukowiscydozy i do indukcji wydzielania jonów
HK1194977A1 (zh) 奈妥比坦與帕洛諾司瓊的具療效的組合
GB201000499D0 (en) Treatment of cystic fibrosis
PT2811993T (pt) Métodos de tratamento da fibrose
GB201311713D0 (en) Cystic fibrosis treatment
AU2012900572A0 (en) Compositions and methods for the treatment of cystic fibrosis
GB201211171D0 (en) Wound dressing and method of treatment
GB201000571D0 (en) Treatment of cystic fibrosis
GB201221118D0 (en) Methods of treatment
GB201216748D0 (en) Methods of treatment
GB201216740D0 (en) Methods of treatment
GB201208591D0 (en) Video game therapy
GB201206330D0 (en) Methods of treatment
GB201206326D0 (en) Methods of treatment
GB201206325D0 (en) Methods of treatment